Global Artificial Intelligence in Precision Medicine Market to reach USD 10,244.52 million at a CAGR of 33.18% by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, The Artificial Intelligence in Precision Medicine market is experiencing significant growth, fueled by the increasing global incidence of chronic and genetic disorders, which has heightened the demand for personalized treatment solutions. This growth is further supported by the rising need for precision diagnostics and customized therapies that utilize AI's ability to process complex biological data. Advancements in AI-driven platforms, along with ongoing innovative product development, are improving the accuracy and efficiency of precision medical interventions.

DelveInsight's "Artificial Intelligence in Precision Medicine Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Artificial Intelligence in Precision Medicine companies actively working in the market.

To know more about why North America is leading the market growth in the Artificial Intelligence in Precision Medicine market, get a snapshot of the report Artificial Intelligence in Precision Medicine Market Trends
https://www.delveinsight.com/sample-request/ai-in-precision-medicine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Artificial Intelligence in Precision Medicine Overview
Artificial Intelligence (AI) in Precision Medicine refers to the use of advanced AI algorithms and machine learning techniques to analyze complex medical data such as genomics, imaging, electronic health records, and biomarkers-to tailor diagnosis, treatment, and prevention strategies for individual patients. By identifying patterns, predicting disease risk, and optimizing therapy selection, AI enables more personalized, effective, and timely healthcare interventions. In precision medicine, AI supports drug discovery, patient stratification, and clinical decision-making, ultimately improving outcomes while minimizing side effects and inefficiencies in treatment.

DelveInsight Analysis: The Artificial Intelligence (AI) in Precision Medicine market size was valued at approximately USD 1,036.91 million in 2024 and is projected to grow at a remarkable CAGR of 33.18% from 2025 to 2032, reaching nearly USD 10,244.52 million by 2032.

Artificial Intelligence in Precision Medicine Market Insights
Geographically, North America is projected to hold the largest share of the Artificial Intelligence in Precision Medicine market during the forecast period from 2025 to 2032. This leadership is attributed to several factors, including the increasing prevalence of chronic disorders such as cancer, lifestyle-related diseases like diabetes, and infectious diseases. Moreover, robust R&D initiatives in AI-based precision medicine, a well-developed healthcare infrastructure, ongoing technological innovations, and regulatory approvals are further supporting the region's market dominance.

To read more about the latest highlights related to Artificial Intelligence in Precision Medicine, get a snapshot of the key highlights entailed in the Artificial Intelligence in Precision Medicine
https://www.delveinsight.com/report-store/ai-in-precision-medicine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Artificial Intelligence in Precision Medicine Market Report
• In April 2025, Illumina Inc. and Tempus AI, Inc. joined forces to advance the clinical implementation of next-generation sequencing tests. By integrating Illumina's cutting-edge AI technologies with Tempus's comprehensive multimodal data platform, the partnership seeks to train genomic algorithms and accelerate the adoption of molecular testing in patient care.
• In June 2024, Avicenna.AI, a prominent medical imaging AI company, obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for CINA-VCF, an AI-driven triage and alert tool developed to identify previously undetected vertebral compression fractures (VCFs) in patients undergoing chest or abdominal CT scans.
• In March 2024, Bayer partnered with Aignostics to drive innovation in next-generation precision oncology. The collaboration aims to co-develop an advanced target identification platform that leverages multimodal patient data and state-of-the-art AI/ML algorithms to improve the accuracy and effectiveness of cancer treatment.
• In June 2023, Illumina Inc., a global pioneer in DNA sequencing and array-based technologies, introduced PrimateAI-3D, an advanced AI algorithm designed to predict disease-causing genetic mutations with exceptional accuracy. This innovation improves early detection of genetic risks and supports the development of more personalized treatment approaches.
• Thus, owing to such developments in the market, rapid growth will be observed in the Artificial Intelligence in Precision Medicine market during the forecast period

Key Players in the Artificial Intelligence in Precision Medicine Market
Some of the key market players operating in the Artificial Intelligence in Precision Medicine market include- TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., and others.

Which MedTech key players in the Artificial Intelligence in Precision Medicine market are set to emerge as the trendsetter explore @ Key Artificial Intelligence in Precision Medicine Companies
https://www.delveinsight.com/sample-request/ai-in-precision-medicine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Artificial Intelligence in Precision Medicine Market Landscape
Rising research and development (R&D) efforts, along with innovative product launches by key industry players, are driving the growth of the AI in Precision Medicine market. For instance, in June 2024, Tempus AI, Inc., a leader in AI-driven precision medicine, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Tempus ECG-AF. This AI-based tool helps identify patients at higher risk of atrial fibrillation/flutter (AF), allowing for earlier and more targeted interventions.
As a result of these factors, the Artificial Intelligence in Precision Medicine market is expected to experience substantial growth during the forecast period from 2025 to 2032.

Scope of the Artificial Intelligence in Precision Medicine Market Report
• Coverage: Global
• Study Period: 2022-2032
• Artificial Intelligence in Precision Medicine Market Segmentation By Device Type: Hardware/Software and Services
• Artificial Intelligence in Precision Medicine Market Segmentation By Technology: Deep Learning, Natural Language Processing, and Machine Learning)
• Artificial Intelligence in Precision Medicine Market Segmentation By Application Channel: Drug Discovery & Development and Disease Diagnostics
• Artificial Intelligence in Precision Medicine Market Segmentation By Therapeutics Area: Oncology, Cardiology, Neurology, Infectious Disease, Immunology, and Others
• Artificial Intelligence in Precision Medicine Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Artificial Intelligence in Precision Medicine Companies: TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Artificial Intelligence in Precision Medicine market will grow by 2032? Click to get a snapshot of the Artificial Intelligence in Precision Medicine Market Analysis
https://www.delveinsight.com/sample-request/ai-in-precision-medicine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.